NASDAQ: AVTE - Aerovate Therapeutics, Inc.

六个月盈利: -90.43%
部门: Healthcare

促销时间表 Aerovate Therapeutics, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

Цена ао 25.65
EBITDA -0.0033
Число акций ао 0.02633 млрд
P/BV 1.67
EV/EBITDA 0.3045
ISIN US0080641071
Сайт https://aerovatetx.com
Валюта usd
IPO date 2021-06-30
Sector Health Care
Industry Biotechnology
Валюта отчета usd
每日价格变化: 0% (2.11)
每周价格变化: +3.43% (2.04)
每月价格变化: +11.05% (1.9)
3个月内价格变化: +15.93% (1.82)
六个月内的价格变化: -90.43% (22.05)
每年价格变化: -81.43% (11.36)
3年内价格变化: -88.9% (19.01)
年初以来价格变化: -85.46% (14.51)
所有参数

低估

姓名 意义 年级
P/S 0 0
P/BV 5.58 2
P/E 0 0
EV/EBITDA -7.23 0
全部的: 2.25

效率

姓名 意义 年级
ROA, % -59.27 0
ROE, % -69 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.0083 10
全部的: 10

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 0 0
盈利能力 Ebitda, % 2364.03 10
盈利能力 EPS, % 104.86 10
全部的: 8
更多详情

机构 体积 分享, %
RA Capital Management, L.P. 8263982 29.66
Sofinnova Investments, Inc. 3758686 13.49
Tcg Crossover Management, Llc 2201274 7.9
Atlas Venture Life Science Advisors, LLC 2039249 7.32
Baker Brothers Advisors, LLC 1680517 6.03
Cormorant Asset Management, LP 1211696 4.35
Frazier Life Sciences Management, L.P. 1204867 4.32
Driehaus Capital Management, LLC 1058209 3.8
Great Point Partners LLC 1037690 3.72
Orbimed Advisors LLC. 756930 2.72

ETF 分享, % 本年盈利能力, % 股息, %
Virtus LifeSci Biotech Clinical Trials ETF 0.06121 63.040315712071 0.33
ProShares Hedge Replication ETF 0.00016 5.9237999659878 1.47892
iShares Micro-Cap ETF 0.00658 36.318555985322 1.54048
iShares Russell 2000 Growth ETF 0.00201 38.042556988 0.6026
iShares Russell 3000 ETF 0.00006 32.57283798366 1.43482
ProShares UltraPro Russell2000 0.00055 89.821266282945 1.47873
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0 39.350070246167 0.60264
Vanguard Russell 2000 ETF 0 35.648084105685 1.48801



导师 职称 支付 出生年份
Mr. Timothy P. Noyes M.B.A. CEO & Director 936.9k 1962 (62 年)
Mr. George A. Eldridge CFO & Treasurer 658.6k 1963 (61 年)
Dr. Marinus Verwijs Ph.D. Chief Technical Officer 439.88k 1976 (48 年)
Dr. Benjamin T. Dake Ph.D. Founder, President, COO & Secretary 435.5k 1976 (48 年)
Dr. Ralph W. Niven M.B.A., M.R, Ph.D., Pharm.S Chief Scientific Officer 372.33k 1960 (64 年)
Mr. Hunter Gillies M.D. Chief Medical Officer 512.74k 1966 (58 年)
Mr. Timothy J. Pigot Chief Commercial Officer 584.6k 1971 (53 年)
Ms. Donna Dea Head of Regulatory Affairs N/A
Ms. Susan Fischer Executive Vice President of Development Operations N/A
Mr. Stephen K. Yu Senior Vice President of Quality N/A

地址: United States, Waltham. MA, 930 Winter Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://aerovatetx.com